| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.08B | 2.18B | 2.24B | 2.37B | 2.37B | 2.17B |
| Gross Profit | 660.13M | 686.80M | 633.70M | 669.10M | 726.60M | 663.60M |
| EBITDA | 219.80M | 243.80M | 237.00M | 268.80M | 325.90M | 276.90M |
| Net Income | 144.41M | 156.80M | 149.20M | 172.70M | 230.90M | 190.70M |
Balance Sheet | ||||||
| Total Assets | 1.40B | 1.32B | 1.32B | 1.49B | 1.45B | 1.20B |
| Cash, Cash Equivalents and Short-Term Investments | 147.90M | 335.60M | 198.50M | 195.80M | 343.80M | 242.50M |
| Total Debt | 134.00M | 142.10M | 179.90M | 197.10M | 206.10M | 165.20M |
| Total Liabilities | 779.60M | 674.80M | 683.70M | 807.90M | 714.50M | 593.90M |
| Stockholders Equity | 616.80M | 644.40M | 634.70M | 678.80M | 731.10M | 601.50M |
Cash Flow | ||||||
| Free Cash Flow | 173.80M | 195.80M | 210.90M | 103.70M | 232.30M | 202.40M |
| Operating Cash Flow | 203.40M | 225.30M | 238.80M | 139.60M | 280.30M | 237.00M |
| Investing Cash Flow | -29.20M | -29.10M | -27.50M | -32.00M | -47.80M | -34.50M |
| Financing Cash Flow | -180.10M | -188.30M | -191.20M | -249.80M | -155.70M | -187.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$7.88B | 18.60 | 82.39% | 5.41% | 14.08% | 15.81% | |
69 Neutral | HK$15.37B | 6.79 | 22.90% | 7.66% | -0.99% | -10.43% | |
69 Neutral | HK$245.06B | 44.55 | 4.90% | 0.54% | 14.38% | -41.96% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | HK$39.54B | 6.27 | 8.59% | 0.63% | 30.73% | 90.08% | |
56 Neutral | HK$14.68B | 37.28 | 3.51% | ― | 3.21% | ― | |
54 Neutral | HK$4.68B | 211.00 | -11.77% | 0.24% | -13.99% | -32.74% |